Admission Date:  [**2183-10-14**]              Discharge Date:   [**2183-10-15**]  Date of Birth:  [**2119-11-18**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Tetracycline / IV Dye, Iodine Containing Contrast Media  Attending:[**Last Name (NamePattern4) 290**] Chief Complaint: carboplatin allergy coming in for desensitization  Major Surgical or Invasive Procedure: none   History of Present Illness: 63F with stage IIIC poorly differentiated primary peritoneal carcinoma, now with disease recurrence and participating in a [**Company 2860**] clinical trial.
She is admitted to the ICU for cycle 4 [**Doctor Last Name **]/taxol therapy with carboplatin desensitization.
When she last received chemotherapy on [**2183-9-2**], a third of the way through the infusion of carboplatin, she developed an intense feeling of heat and generalized body tingling, tingling and numbness of the lips, and chest tightness.
Carboplatin was discontinued and she received 100 mg hydrocortisone and 50 mg of Benadryl IV.
Given her allergic reaction, she was admitted to the ICU on [**9-23**] to receive carboplatin per the desensitization protocol.
She tolerated the treatment without incident.
Today, she is directly admitted to the ICU again for carboplatin desensitization.
Denies chest pain, chest pressure, palpitations.
Past Medical History: - CT abd/pelvis on [**2182-2-28**] revealed a large mass centered in the sigmoid colon with pelvic lymphadenopathy, retroperitoneal lymphadenopathy, and peritoneal carcinomatosis.
- [**2182-3-14**] underwent exploratory laparotomy, hysterectomy, bilateral salpingo-oophorectomy, rectosigmoid resection with colorectal re-anastomosis and diverting loop ileostomy.
- [**4-26**] start chemotherapy with Carboplatin q21d and weekly Taxol - [**2182-5-30**] Cycle 3 Carboplatin and Taxol - Thalassemia  Social History: Imigrated from [**Country 3587**] in youth.
Skin: Right chest port in place  Discharge Exam: Vitals: T 98.4, BP 149/86, HR 82, RR 22, 99% on RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding, vertical midline scar GU: no foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, 5/5 strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred.
Skin: Right chest port in place     Pertinent Results: Admission labs:  [**2183-10-14**] 01:45PM   ALT(SGPT)-41* AST(SGOT)-27 ALK PHOS-116* TOT BILI-0.3  Discharge Labs:  [**2183-10-15**] 03:18AM BLOOD WBC-7.6 RBC-3.70* Hgb-8.4* Hct-25.8* MCV-70* MCH-22.7* MCHC-32.6 RDW-20.0* Plt Ct-214 [**2183-10-15**] 03:18AM BLOOD Plt Ct-214 [**2183-10-15**] 03:18AM BLOOD Glucose-193* UreaN-24* Creat-0.9 Na-139 K-4.3 Cl-105 HCO3-24 AnGap-14 [**2183-10-15**] 03:18AM BLOOD ALT-33 AST-25 AlkPhos-106* TotBili-0.3  [**10-13**] EKG: Normal sinus rhythm.
Micro: None  Imaging: None  Brief Hospital Course: Brief Hospital COurse: 63F with stage IIIC poorly differentiated primary peritoneal carcinoma, now with disease recurrence and participating in a [**Company 2860**] clinical trial admitted to ICU for carboplatin desensitization.
Patient tolerated the treatment well without adverse effects.
Active Issues: # Carboplatin desensitization: Patient has experienced feeling of heat, generalized body tingling, numbness of the lips, chest tightness,nausea, and headache with prior carboplatin infusion.
She was last admitted to the ICU in [**Month (only) 216**] for carboplatin desensitization via protocol and tolerated in well.
We followed the same protocol during this treatment course with premedication with diphenhydramine, famotidine, lorazepam and epinephrine and diphenhydramine prn ordered in event of reaction.
The patient tolerated the treatment well and had no signs of hypersenstivity or adverse reaction.
# Stage IIIc poorly differentiated primary peritoneal serous carcinoma: Status post sub-optimal debulking surgery ([**2182-3-14**]) and 6 cycles ofchemotherapy ([**4-/2182**]/[**2182**]).
Five cycles with Carboplatin and weekly Taxol and 1 cycle with Carboplatin and Taxotere.
On [**8-11**] she started chemotherapy according to the clinical trial [**Company 2860**] #11-228 (Phase II, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with Carboplatin/Paclitaxel).
The second cycle was complicated by an allergic reaction to Carboplatin and cycle 3 was administered without complication with desensitization protocol.
She will follow up with her oncologist to schedule further chemotherapy treatments.
Pending studies: None  Medications on Admission: Zofran for nausea   Discharge Medications: Zofran for nausea   Discharge Disposition: Home  Discharge Diagnosis: -Stage IIIc poorly differentiated primary peritoneal serous carcinoma -Carboplatin desensitization   Discharge Condition: Mental Status: Clear and coherent.
You were treated with a regimen to decrease your allergic reaction to this medication, which worked well, and you were discharged home.
You will need this treatment prior to each of your future treatments with this medication.
